Finance

Lists
ABL:ETR
Abbott Laboratories
89,12 €
-0,13%
(-0,12) 1D
6-окт., 13:17:41 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ABL...
Open
89,54 €
High
89,54 €
Low
88,88 €
Mkt. cap
167,40 млд
Avg. vol.
831,00
Volume
36,00
52-wk high
116,50 €
52-wk low
70,10 €
No. of employees
115 миң
Open
89,54 €
High
89,54 €
Low
88,88 €
Mkt. cap
167,40 млд
Avg. vol.
831,00
Volume
36,00
52-wk high
116,50 €
52-wk low
70,10 €
No. of employees
115 миң
News stories
From web sources and news partners
Profile
Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company founded in Chicago with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices. Abbott operates in over 160 countries and sources from at least 62 suppliers worldwide. Abbott's products include Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip. The company is ranked 107th on the Fortune 500 and 144th on the Forbes Global 2000. Wikipedia
About Abbott Laboratories
CEORobert B. Ford
Employees115 миң
Founded1888
HeadquartersЧикаго, Иллинойс, Америка Кошмо Штаттары
SectorMedical device
Websiteabbott.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
11,37 млд
11,46 млд
11,16 млд
12,59 млд
Cost of goods sold
5,08 млд
4,91 млд
4,89 млд
5,32 млд
Cost of revenue
5,08 млд
4,91 млд
4,89 млд
5,32 млд
Research and development expenses
766,00 млн
720,00 млн
767,00 млн
892,00 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,90 млд
2,93 млд
3,58 млд
3,87 млд
Operating expense
4,09 млд
4,07 млд
4,77 млд
5,42 млд
Total operating expenses
9,16 млд
8,98 млд
9,66 млд
10,74 млд
Operating income
2,20 млд
2,48 млд
1,50 млд
1,85 млд
Other non operating income
2,00 млн
-15,00 млн
-
-25,00 млн
EBT including unusual items
2,18 млд
2,36 млд
1,45 млд
1,52 млд
EBT excluding unusual items
2,18 млд
2,44 млд
1,45 млд
1,52 млд
Income tax expense
536,00 млн
582,00 млн
372,00 млн
596,00 млн
Effective tax rate
24,59%
24,68%
25,67%
39,11%
Other operating expenses
-
-
-
-
Net income
1,64 млд
1,78 млд
1,08 млд
928,00 млн
Net profit margin
14,46%
15,50%
9,65%
7,37%
Earnings per share
1,30
1,50
1,15
1,31
Interest and investment income
77,00 млн
78,00 млн
106,00 млн
52,00 млн
Interest expense
-121,00 млн
-120,00 млн
-174,00 млн
-351,00 млн
Net interest expenses
-44,00 млн
-42,00 млн
-68,00 млн
-299,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
3,00 млд
3,27 млд
2,31 млд
2,91 млд
Gain or loss from assets sale
-
65,00 млн
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору